TG Therapeutics, Inc. (TGTX)
56.74
-0.16
(-0.28%)
USD |
NASDAQ |
Sep 03, 15:07
TG Therapeutics Net Income (Annual) : 447.18M for Dec. 31, 2025
Net Income (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Net Income (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | 447.18M |
| December 31, 2024 | 23.38M |
| December 31, 2023 | 12.67M |
| December 31, 2022 | -198.34M |
| December 31, 2021 | -348.10M |
| December 31, 2020 | -279.38M |
| December 31, 2019 | -172.87M |
| December 31, 2018 | -173.48M |
| December 31, 2017 | -118.48M |
| December 31, 2016 | -78.25M |
| December 31, 2015 | -62.95M |
| December 31, 2014 | -55.78M |
| December 31, 2013 | -20.48M |
| December 31, 2012 | -26.18M |
| Date | Value |
|---|---|
| December 31, 2011 | -0.8891M |
| December 31, 2010 | 0.6236M |
| December 31, 2009 | -2.793M |
| December 31, 2008 | -4.269M |
| December 31, 2007 | -12.03M |
| December 31, 2006 | -9.695M |
| December 31, 2005 | -19.14M |
| December 31, 2004 | -5.896M |
| December 31, 2003 | -5.961M |
| December 31, 2002 | -1.547M |
| December 31, 2001 | -0.8977M |
| December 31, 2000 | -5.802M |
| December 31, 1999 | -2.446M |
| December 31, 1998 | -2.754M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Annual) Benchmarks
| Krystal Biotech, Inc. | 204.83M |
| MAIA Biotechnology, Inc. | -22.40M |
| Alnylam Pharmaceuticals, Inc. | 313.75M |
| BioMarin Pharmaceutical, Inc. | 348.90M |
| Cytokinetics, Inc. | -784.96M |